Navigation Links
DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma
Date:8/18/2009

The ORADUR Technology is a patented technology designed to transform short-acting oral capsule dosage forms into sustained release oral products, with the added benefit of being less prone to common methods of abuse and misuse than other controlled release dosage forms on the market today. REMOXY(R), a long acting oral formulation of oxycodone based on the ORADUR Technology intended to treat moderate to severe pain, has been submitted for and is awaiting approval with the U.S. Food and Drug Administration (FDA).

About DURECT Corporation

DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY(R), POSIDUR(TM), ELADUR(TM), and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit www.durect.com.

NOTE: POSIDUR(TM), SABER(TM), ORADUR(R), TRANSDUR(TM), and ELADUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the FDA or other health authorities.

About Orient Pharma Co., Ltd.

Orient Pharma was established in 2008 and is located in the Central Taiwan Science Park in Yunlin. Orient Pharma is building a new pharmaceutical manufacturing facility that is designed to comply with the international standards of the U.S. FDA and the European PIC/S. The first phase of the project is expected
'/>"/>

SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DURECT Corporation Announces Second Quarter 2009 Financial
2. DURECT to Present at the BMO Capital Markets Healthcare Conference
3. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
4. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
5. DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call
6. DURECT to Participate in Cowen and Company Healthcare Conference
7. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
8. DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call
9. DURECT Corporation to Participate in Upcoming Healthcare Conferences
10. DURECT Corporation to Participate in Upcoming Healthcare Conferences
11. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Times highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. ... U.S. Secretary of State looks more youthful than she has in some time ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for Disease Control ... , and the Multicultural AIDS Coalition $3.78 million for a five-year HIV ... with men (MSM) and transgender women, the groups at highest risk of HIV ...
(Date:7/7/2015)... Fremont, California (PRWEB) , ... July 07, 2015 ... ... access connectivity solutions, today announced the CelestixEdge VE and CelestixFederated VA Series virtual ... E and CelestixFederated A Series portfolio of products, which have proven to simplify ...
(Date:7/7/2015)... ... 07, 2015 , ... Illinois cannabis cultivation centers and dispensary ... holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its members have ... to making sure patients have access to cannabis as a viable medical treatment ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... global provider of advanced delivery technologies and development solutions for drugs, biologics ... licensing agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2
... stem cells, which may provide a treatment for tumors ... pancreatic cancer, according to new research from Memorial Sloan-Kettering ... important since pancreatic cancer has a poor prognosis and ... Investigators led by Joyce Wong, MD, surgical researcher ...
... , NEW YORK (May 6, 2011) -- Among ... meeting are physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical ... McCormick Place, Chicago. The following are two notable ... A gastroenterologist at NewYork-Presbyterian Hospital/Columbia University Medical Center ...
... gene expression of their lungs similar to that suffered by ... is the conclusion of a new study, led by Catalan ... causing these alterations. "Our objective was to analyse the ... samples of patients with COPD, whether smokers or not, and ...
... up to a year before a patient is diagnosed with ... often mistaken for other diseases. However, with this blood-based test, ... disease or not", says Christer Wingren, associate professor in Immunotechnology ... determine how far the disease has progressed. There are three ...
... post-mortem tissue archive for a study of the human form ... by coroners to participate. The Coroners, Society of England and ... public health" from potential new risks associated with variant Creutzfeldt-Jakob ... of tissue from autopsies. That is the conclusion of a ...
... (HealthDay News) -- Children conceived in winter seem to have ... study suggests. Environmental factors -- including exposure to seasonal ... play a role in the greater risk for autism among ... California, Davis researchers. The investigators analyzed data from 6.6 ...
Cached Medicine News:Health News:Oncolytic viruses effectively target and kill pancreatic cancer stem cells 2Health News:NY Presbyterian/Columbia research presented at Digestive Disease Week meeting 2Health News:Smokers undergo the same changes in gene expression as patients with COPD 2Health News:New test could give SLE patients a more tolerable life 2Health News:Coroners wrong to say no to post-mortem tissue collection, academics argue 2Health News:Winter Conception Tied to Raised Risk for Autism 2
(Date:7/7/2015)... , July 7, 2015 BioRx, a Diplomat ... recognized as a Top Workplace in 2015 based on a ... the Enquirer Media Group and a Philadelphia ... 22 questions and was completed by employees across the ... area, with topics ranging from workplace environment to ...
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... Welch Allyn for $2 billion in cash and ... competitive patient monitoring market, according to Kalorama Information. ... heretofore participated in the medical device and advanced ... maker of hospital beds, patient lifting devices, and ...
(Date:7/7/2015)... 7, 2015   ICD-10 Charts ( www.icd10charts.com ... development, it has officially launched its newest line ... Academy and the new 4 Step ICD-10 Implementation ... all other ICD-10 Charts resources and mobile apps, ... completely free-of-charge.  With the release of these resources, ...
Breaking Medicine Technology:BioRx Named a Top Workplace in 2015 by Enquirer Media 2BioRx Named a Top Workplace in 2015 by Enquirer Media 3Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4
... Varian Medical Systems (NYSE: VAR ) is ... at 9:30 a.m. ET on Wednesday, November 17th at ... Participating executives will include Elisha Finney, senior vice ... investor relations and corporate communications. The presentation will focus ...
... GREENSBORO, N.C., Nov. 5, 2010 Merz Pharmaceuticals announced ... Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from ... Assembly of the American Academy of Physical Medicine and ... U.S. Food and Drug Administration (FDA) approved XEOMIN on ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 2Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 3Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 4Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 5Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 6
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: